Search clinical trials for: Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer
Total 93543 results
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
Merck Sharp & Dohme LLCTerminated
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; Northwestern University; Oregon Health and Science UniversityActive, not recruiting
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
IpsenTerminatedProstatic Neoplasms, Castration-ResistantChina, Korea, Republic of, Taiwan
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Lawrence FongBristol-Myers Squibb; SanofiWithdrawn
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
University of WashingtonNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Xencor, Inc.RecruitingMetastatic Castration-Resistant Prostate CancerUnited States
-
Tianjin Medical University Second HospitalRecruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticChina
-
National Cancer Institute (NCI)Active, not recruitingClinical Stage III Gastric Cancer AJCC v8 | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Metastatic Gastroesophageal Junction Adenocarcinoma | Metastatic... and other conditionsUnited States
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic NeoplasmsUnited States, Australia, France, Germany, United Kingdom, Belgium, Spain, Argentina, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Mexico
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
The University of Texas Health Science Center at...WithdrawnMetastatic Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate Adenocarcinoma | Castrate Resistant Prostate CancerUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedMetastatic Prostate Cancer | Castration Resistant Prostatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedUrothelial Carcinoma | Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Bladder Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage III Urethral Cancer AJCC v8 | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral... and other conditionsUnited States
-
MANA RBMBayer; Tulane University; Barbara Ann Karmanos Cancer Institute; Carolina Urologic...TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
University Hospital Southampton NHS Foundation...AstraZeneca; Cancer Research UKCompletedProstate CancerUnited Kingdom
-
UNICANCERInstitut Bergonié; National Cancer Institute, France; Institut du Cancer de Montpellier...CompletedChemotherapy | Castration-resistant Prostate Cancer | Prostate Carcinoma | Circulating Tumor CellsFrance
-
UNICANCERCompleted
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompleted
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Spanish Oncology Genito-Urinary GroupApices Soluciones S.L.; Janssen, LPCompleted
-
Universität des SaarlandesCompleted
-
IpsenTerminatedMetastatic Castrate Resistant Prostate CancerFrance, Spain, Poland, Belgium, Germany, Italy, Denmark, Lithuania, United Kingdom, Czechia, Hungary
-
Bristol-Myers SquibbCompletedProstate CancerAustralia, United States, Chile, Spain, France, Italy, United Kingdom, Germany, Netherlands
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedProstate CancerTaiwan, Korea, Republic of
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
SOTIO a.s.CompletedProstate Cancer | Prostate Cancer MetastaticCzechia
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
Stanford UniversityTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaboratorsCompletedMetastatic Prostate CancerFinland
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
Oncology Specialists, S.C.Wyeth is now a wholly owned subsidiary of PfizerCompletedProstate CancerUnited States
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Austria, Netherlands, Ireland, Hungary
-
GenSpera, Inc.WithdrawnProstate Cancer.United States
-
Aarhus University HospitalRigshospitalet, DenmarkTerminatedProstate Cancer | MetastasisDenmark
-
PfizerTerminatedProstatic NeoplasmsUnited States, Canada, Spain, Belgium, Finland, Italy, Korea, Republic of, Poland, Portugal, Slovakia, Sweden, Denmark, Taiwan, China, Australia, Germany, Israel, United Kingdom, Brazil, France, Czech Republic, Peru
-
Genta IncorporatedUnknownProstate CancerUnited States